世界のコラーゲン・HAベース生体材料市場インサイト及び予測(~2026年)

【英語タイトル】Global Collagen and HA-Based Biomaterials Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV00409)・商品コード:QYR20NV00409
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはコラーゲン・HAベース生体材料の世界市場について調査・分析した資料です。種類別(尿失禁、角膜シールド、フェイシャルエステティックダーマルフィラー、創傷被覆材、その他)の市場規模、用途別(美容、創傷ケア、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別コラーゲン・HAベース生体材料の競争状況、市場シェア
・世界のコラーゲン・HAベース生体材料市場:種類別市場規模 2015年-2020年(尿失禁、角膜シールド、フェイシャルエステティックダーマルフィラー、創傷被覆材、その他)
・世界のコラーゲン・HAベース生体材料市場:種類別市場規模予測 2021年-2026年(尿失禁、角膜シールド、フェイシャルエステティックダーマルフィラー、創傷被覆材、その他)
・世界のコラーゲン・HAベース生体材料市場:用途別市場規模 2015年-2020年(美容、創傷ケア、その他)
・世界のコラーゲン・HAベース生体材料市場:用途別市場規模予測 2021年-2026年(美容、創傷ケア、その他)
・北米のコラーゲン・HAベース生体材料市場分析:米国、カナダ
・ヨーロッパのコラーゲン・HAベース生体材料市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのコラーゲン・HAベース生体材料市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のコラーゲン・HAベース生体材料市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのコラーゲン・HAベース生体材料市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Johnson & Johnson、Alcon Laboratories(US)、Allergan(US)、Anika Therapeutics(US)、Bausch & Lomb(US)、Collagen Solutions Plc. (UK)、Galderma (Switzerland)、Genzyme (US)、Lifecore Biomedical, LLC (US)、Seikagaku Corp. (Japan)、Teijin Pharma Limited (Japan)
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

A biomaterial is any substance that has been engineered to interact with biological systems for a medical purpose – either a therapeutic (treat, augment, repair or replace a tissue function of the body) or a diagnostic one. As a science, biomaterials is about fifty years old. Hyaluronic acid (HA) is a substance which is naturally present in the human body with highest concentration in the eye and joints. It has wide applications in the field of osteoarthritis, eye surgery, plastic surgery, prevention of aging etc.
Geographically, North America holds a leading position with regards to collagen and HA-based biomaterials market followed by the European market. Some of the major factors responsible for the growth of this market in these regions are increasing prevalence of various diseases, development of new and technologically advanced products, use of single-injection visco supplement products, and increasing need of individuals to stay fit and healthy in their advancing years. Asia-Pacific is one of the most lucrative markets for the expansion of collagen and HA-based biomaterials. This region is growing and developing at a rapid pace. The prime reasons which will proliferate the growth of this market in the Asia-Pacific region are high market penetration, increasing demand for tissue regeneration in developing regions, increasing number of elderly people with chronic arthritis due to high population density in countries like China and India, increasing need of individuals to opt for anti-aging treatments in order to enhance their physical appearance, and rising disposable income of the people to spend on sophisticated and advanced technologies.

Market Analysis and Insights: Global Collagen and HA-Based Biomaterials Market
The global Collagen and HA-Based Biomaterials market size is projected to reach US$ 5466.7 million by 2026, from US$ 5251 million in 2020, at a CAGR of 3.8%% during 2021-2026.

Global Collagen and HA-Based Biomaterials Scope and Market Size
Collagen and HA-Based Biomaterials market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Collagen and HA-Based Biomaterials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Collagen and HA-Based Biomaterials market is segmented into
Urinary Incontinence
Corneal Shields
Facial Aesthetic Dermal Fillers
Wound Dressings
Others

Segment by Application, the Collagen and HA-Based Biomaterials market is segmented into
Cosmetology
Wound Care
Others

Regional and Country-level Analysis
The Collagen and HA-Based Biomaterials market is analysed and market size information is provided by regions (countries).
The key regions covered in the Collagen and HA-Based Biomaterials market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Collagen and HA-Based Biomaterials Market Share Analysis
Collagen and HA-Based Biomaterials market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Collagen and HA-Based Biomaterials business, the date to enter into the Collagen and HA-Based Biomaterials market, Collagen and HA-Based Biomaterials product introduction, recent developments, etc.

The major vendors covered:
Johnson & Johnson
Alcon Laboratories(US)
Allergan(US)
Anika Therapeutics(US)
Bausch & Lomb(US)
Collagen Solutions Plc. (UK)
Galderma (Switzerland)
Genzyme (US)
Lifecore Biomedical, LLC (US)
Seikagaku Corp. (Japan)
Teijin Pharma Limited (Japan)

【レポートの目次】

1 Study Coverage
1.1 Collagen and HA-Based Biomaterials Product Introduction
1.2 Market Segments
1.3 Key Collagen and HA-Based Biomaterials Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Collagen and HA-Based Biomaterials Market Size Growth Rate by Type
1.4.2 Urinary Incontinence
1.4.3 Corneal Shields
1.4.4 Facial Aesthetic Dermal Fillers
1.4.5 Wound Dressings
1.4.6 Others
1.5 Market by Application
1.5.1 Global Collagen and HA-Based Biomaterials Market Size Growth Rate by Application
1.5.2 Cosmetology
1.5.3 Wound Care
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Collagen and HA-Based Biomaterials Market Size, Estimates and Forecasts
2.1.1 Global Collagen and HA-Based Biomaterials Revenue 2015-2026
2.1.2 Global Collagen and HA-Based Biomaterials Sales 2015-2026
2.2 Global Collagen and HA-Based Biomaterials, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Collagen and HA-Based Biomaterials Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Collagen and HA-Based Biomaterials Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Collagen and HA-Based Biomaterials Competitor Landscape by Players
3.1 Collagen and HA-Based Biomaterials Sales by Manufacturers
3.1.1 Collagen and HA-Based Biomaterials Sales by Manufacturers (2015-2020)
3.1.2 Collagen and HA-Based Biomaterials Sales Market Share by Manufacturers (2015-2020)
3.2 Collagen and HA-Based Biomaterials Revenue by Manufacturers
3.2.1 Collagen and HA-Based Biomaterials Revenue by Manufacturers (2015-2020)
3.2.2 Collagen and HA-Based Biomaterials Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Collagen and HA-Based Biomaterials Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Collagen and HA-Based Biomaterials Revenue in 2019
3.2.5 Global Collagen and HA-Based Biomaterials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Collagen and HA-Based Biomaterials Price by Manufacturers
3.4 Collagen and HA-Based Biomaterials Manufacturing Base Distribution, Product Types
3.4.1 Collagen and HA-Based Biomaterials Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Collagen and HA-Based Biomaterials Product Type
3.4.3 Date of International Manufacturers Enter into Collagen and HA-Based Biomaterials Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Collagen and HA-Based Biomaterials Market Size by Type (2015-2020)
4.1.1 Global Collagen and HA-Based Biomaterials Sales by Type (2015-2020)
4.1.2 Global Collagen and HA-Based Biomaterials Revenue by Type (2015-2020)
4.1.3 Collagen and HA-Based Biomaterials Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Collagen and HA-Based Biomaterials Market Size Forecast by Type (2021-2026)
4.2.1 Global Collagen and HA-Based Biomaterials Sales Forecast by Type (2021-2026)
4.2.2 Global Collagen and HA-Based Biomaterials Revenue Forecast by Type (2021-2026)
4.2.3 Collagen and HA-Based Biomaterials Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Collagen and HA-Based Biomaterials Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Collagen and HA-Based Biomaterials Market Size by Application (2015-2020)
5.1.1 Global Collagen and HA-Based Biomaterials Sales by Application (2015-2020)
5.1.2 Global Collagen and HA-Based Biomaterials Revenue by Application (2015-2020)
5.1.3 Collagen and HA-Based Biomaterials Price by Application (2015-2020)
5.2 Collagen and HA-Based Biomaterials Market Size Forecast by Application (2021-2026)
5.2.1 Global Collagen and HA-Based Biomaterials Sales Forecast by Application (2021-2026)
5.2.2 Global Collagen and HA-Based Biomaterials Revenue Forecast by Application (2021-2026)
5.2.3 Global Collagen and HA-Based Biomaterials Price Forecast by Application (2021-2026)

6 North America
6.1 North America Collagen and HA-Based Biomaterials by Country
6.1.1 North America Collagen and HA-Based Biomaterials Sales by Country
6.1.2 North America Collagen and HA-Based Biomaterials Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Collagen and HA-Based Biomaterials Market Facts & Figures by Type
6.3 North America Collagen and HA-Based Biomaterials Market Facts & Figures by Application

7 Europe
7.1 Europe Collagen and HA-Based Biomaterials by Country
7.1.1 Europe Collagen and HA-Based Biomaterials Sales by Country
7.1.2 Europe Collagen and HA-Based Biomaterials Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Collagen and HA-Based Biomaterials Market Facts & Figures by Type
7.3 Europe Collagen and HA-Based Biomaterials Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Collagen and HA-Based Biomaterials by Region
8.1.1 Asia Pacific Collagen and HA-Based Biomaterials Sales by Region
8.1.2 Asia Pacific Collagen and HA-Based Biomaterials Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Collagen and HA-Based Biomaterials Market Facts & Figures by Type
8.3 Asia Pacific Collagen and HA-Based Biomaterials Market Facts & Figures by Application

9 Latin America
9.1 Latin America Collagen and HA-Based Biomaterials by Country
9.1.1 Latin America Collagen and HA-Based Biomaterials Sales by Country
9.1.2 Latin America Collagen and HA-Based Biomaterials Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Collagen and HA-Based Biomaterials Market Facts & Figures by Type
9.3 Central & South America Collagen and HA-Based Biomaterials Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Collagen and HA-Based Biomaterials by Country
10.1.1 Middle East and Africa Collagen and HA-Based Biomaterials Sales by Country
10.1.2 Middle East and Africa Collagen and HA-Based Biomaterials Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Collagen and HA-Based Biomaterials Market Facts & Figures by Type
10.3 Middle East and Africa Collagen and HA-Based Biomaterials Market Facts & Figures by Application

11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Collagen and HA-Based Biomaterials Products Offered
11.1.5 Johnson & Johnson Related Developments
11.2 Alcon Laboratories(US)
11.2.1 Alcon Laboratories(US) Corporation Information
11.2.2 Alcon Laboratories(US) Description and Business Overview
11.2.3 Alcon Laboratories(US) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Alcon Laboratories(US) Collagen and HA-Based Biomaterials Products Offered
11.2.5 Alcon Laboratories(US) Related Developments
11.3 Allergan(US)
11.3.1 Allergan(US) Corporation Information
11.3.2 Allergan(US) Description and Business Overview
11.3.3 Allergan(US) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Allergan(US) Collagen and HA-Based Biomaterials Products Offered
11.3.5 Allergan(US) Related Developments
11.4 Anika Therapeutics(US)
11.4.1 Anika Therapeutics(US) Corporation Information
11.4.2 Anika Therapeutics(US) Description and Business Overview
11.4.3 Anika Therapeutics(US) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Anika Therapeutics(US) Collagen and HA-Based Biomaterials Products Offered
11.4.5 Anika Therapeutics(US) Related Developments
11.5 Bausch & Lomb(US)
11.5.1 Bausch & Lomb(US) Corporation Information
11.5.2 Bausch & Lomb(US) Description and Business Overview
11.5.3 Bausch & Lomb(US) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bausch & Lomb(US) Collagen and HA-Based Biomaterials Products Offered
11.5.5 Bausch & Lomb(US) Related Developments
11.6 Collagen Solutions Plc. (UK)
11.6.1 Collagen Solutions Plc. (UK) Corporation Information
11.6.2 Collagen Solutions Plc. (UK) Description and Business Overview
11.6.3 Collagen Solutions Plc. (UK) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Collagen Solutions Plc. (UK) Collagen and HA-Based Biomaterials Products Offered
11.6.5 Collagen Solutions Plc. (UK) Related Developments
11.7 Galderma (Switzerland)
11.7.1 Galderma (Switzerland) Corporation Information
11.7.2 Galderma (Switzerland) Description and Business Overview
11.7.3 Galderma (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Galderma (Switzerland) Collagen and HA-Based Biomaterials Products Offered
11.7.5 Galderma (Switzerland) Related Developments
11.8 Genzyme (US)
11.8.1 Genzyme (US) Corporation Information
11.8.2 Genzyme (US) Description and Business Overview
11.8.3 Genzyme (US) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Genzyme (US) Collagen and HA-Based Biomaterials Products Offered
11.8.5 Genzyme (US) Related Developments
11.9 Lifecore Biomedical, LLC (US)
11.9.1 Lifecore Biomedical, LLC (US) Corporation Information
11.9.2 Lifecore Biomedical, LLC (US) Description and Business Overview
11.9.3 Lifecore Biomedical, LLC (US) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Lifecore Biomedical, LLC (US) Collagen and HA-Based Biomaterials Products Offered
11.9.5 Lifecore Biomedical, LLC (US) Related Developments
11.10 Seikagaku Corp. (Japan)
11.10.1 Seikagaku Corp. (Japan) Corporation Information
11.10.2 Seikagaku Corp. (Japan) Description and Business Overview
11.10.3 Seikagaku Corp. (Japan) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Seikagaku Corp. (Japan) Collagen and HA-Based Biomaterials Products Offered
11.10.5 Seikagaku Corp. (Japan) Related Developments
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Collagen and HA-Based Biomaterials Products Offered
11.1.5 Johnson & Johnson Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Collagen and HA-Based Biomaterials Market Estimates and Projections by Region
12.1.1 Global Collagen and HA-Based Biomaterials Sales Forecast by Regions 2021-2026
12.1.2 Global Collagen and HA-Based Biomaterials Revenue Forecast by Regions 2021-2026
12.2 North America Collagen and HA-Based Biomaterials Market Size Forecast (2021-2026)
12.2.1 North America: Collagen and HA-Based Biomaterials Sales Forecast (2021-2026)
12.2.2 North America: Collagen and HA-Based Biomaterials Revenue Forecast (2021-2026)
12.2.3 North America: Collagen and HA-Based Biomaterials Market Size Forecast by Country (2021-2026)
12.3 Europe Collagen and HA-Based Biomaterials Market Size Forecast (2021-2026)
12.3.1 Europe: Collagen and HA-Based Biomaterials Sales Forecast (2021-2026)
12.3.2 Europe: Collagen and HA-Based Biomaterials Revenue Forecast (2021-2026)
12.3.3 Europe: Collagen and HA-Based Biomaterials Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Collagen and HA-Based Biomaterials Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Collagen and HA-Based Biomaterials Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Collagen and HA-Based Biomaterials Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Collagen and HA-Based Biomaterials Market Size Forecast by Region (2021-2026)
12.5 Latin America Collagen and HA-Based Biomaterials Market Size Forecast (2021-2026)
12.5.1 Latin America: Collagen and HA-Based Biomaterials Sales Forecast (2021-2026)
12.5.2 Latin America: Collagen and HA-Based Biomaterials Revenue Forecast (2021-2026)
12.5.3 Latin America: Collagen and HA-Based Biomaterials Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Collagen and HA-Based Biomaterials Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Collagen and HA-Based Biomaterials Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Collagen and HA-Based Biomaterials Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Collagen and HA-Based Biomaterials Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Collagen and HA-Based Biomaterials Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Collagen and HA-Based Biomaterials Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Collagen and HA-Based Biomaterials Market Segments
Table 2. Ranking of Global Top Collagen and HA-Based Biomaterials Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Collagen and HA-Based Biomaterials Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Urinary Incontinence
Table 5. Major Manufacturers of Corneal Shields
Table 6. Major Manufacturers of Facial Aesthetic Dermal Fillers
Table 7. Major Manufacturers of Wound Dressings
Table 8. Major Manufacturers of Others
Table 9. Global Collagen and HA-Based Biomaterials Market Size Growth Rate by Application 2020-2026 (K MT)
Table 10. Global Collagen and HA-Based Biomaterials Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 11. Global Collagen and HA-Based Biomaterials Sales by Regions 2015-2020 (K MT)
Table 12. Global Collagen and HA-Based Biomaterials Sales Market Share by Regions (2015-2020)
Table 13. Global Collagen and HA-Based Biomaterials Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Collagen and HA-Based Biomaterials Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global Collagen and HA-Based Biomaterials Sales Share by Manufacturers (2015-2020)
Table 16. Global Collagen and HA-Based Biomaterials Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Collagen and HA-Based Biomaterials by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Collagen and HA-Based Biomaterials as of 2019)
Table 18. Collagen and HA-Based Biomaterials Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Collagen and HA-Based Biomaterials Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Collagen and HA-Based Biomaterials Price (2015-2020) (USD/MT)
Table 21. Collagen and HA-Based Biomaterials Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Collagen and HA-Based Biomaterials Product Type
Table 23. Date of International Manufacturers Enter into Collagen and HA-Based Biomaterials Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Collagen and HA-Based Biomaterials Sales by Type (2015-2020) (K MT)
Table 26. Global Collagen and HA-Based Biomaterials Sales Share by Type (2015-2020)
Table 27. Global Collagen and HA-Based Biomaterials Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Collagen and HA-Based Biomaterials Revenue Share by Type (2015-2020)
Table 29. Collagen and HA-Based Biomaterials Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Collagen and HA-Based Biomaterials Sales by Application (2015-2020) (K MT)
Table 31. Global Collagen and HA-Based Biomaterials Sales Share by Application (2015-2020)
Table 32. North America Collagen and HA-Based Biomaterials Sales by Country (2015-2020) (K MT)
Table 33. North America Collagen and HA-Based Biomaterials Sales Market Share by Country (2015-2020)
Table 34. North America Collagen and HA-Based Biomaterials Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Collagen and HA-Based Biomaterials Revenue Market Share by Country (2015-2020)
Table 36. North America Collagen and HA-Based Biomaterials Sales by Type (2015-2020) (K MT)
Table 37. North America Collagen and HA-Based Biomaterials Sales Market Share by Type (2015-2020)
Table 38. North America Collagen and HA-Based Biomaterials Sales by Application (2015-2020) (K MT)
Table 39. North America Collagen and HA-Based Biomaterials Sales Market Share by Application (2015-2020)
Table 40. Europe Collagen and HA-Based Biomaterials Sales by Country (2015-2020) (K MT)
Table 41. Europe Collagen and HA-Based Biomaterials Sales Market Share by Country (2015-2020)
Table 42. Europe Collagen and HA-Based Biomaterials Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Collagen and HA-Based Biomaterials Revenue Market Share by Country (2015-2020)
Table 44. Europe Collagen and HA-Based Biomaterials Sales by Type (2015-2020) (K MT)
Table 45. Europe Collagen and HA-Based Biomaterials Sales Market Share by Type (2015-2020)
Table 46. Europe Collagen and HA-Based Biomaterials Sales by Application (2015-2020) (K MT)
Table 47. Europe Collagen and HA-Based Biomaterials Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Collagen and HA-Based Biomaterials Sales by Region (2015-2020) (K MT)
Table 49. Asia Pacific Collagen and HA-Based Biomaterials Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Collagen and HA-Based Biomaterials Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Collagen and HA-Based Biomaterials Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Collagen and HA-Based Biomaterials Sales by Type (2015-2020) (K MT)
Table 53. Asia Pacific Collagen and HA-Based Biomaterials Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Collagen and HA-Based Biomaterials Sales by Application (2015-2020) (K MT)
Table 55. Asia Pacific Collagen and HA-Based Biomaterials Sales Market Share by Application (2015-2020)
Table 56. Latin America Collagen and HA-Based Biomaterials Sales by Country (2015-2020) (K MT)
Table 57. Latin America Collagen and HA-Based Biomaterials Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Collagen and HA-Based Biomaterials Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Collagen and HA-Based Biomaterials Revenue Market Share by Country (2015-2020)
Table 60. Latin America Collagen and HA-Based Biomaterials Sales by Type (2015-2020) (K MT)
Table 61. Latin America Collagen and HA-Based Biomaterials Sales Market Share by Type (2015-2020)
Table 62. Latin America Collagen and HA-Based Biomaterials Sales by Application (2015-2020) (K MT)
Table 63. Latin America Collagen and HA-Based Biomaterials Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Collagen and HA-Based Biomaterials Sales by Country (2015-2020) (K MT)
Table 65. Middle East and Africa Collagen and HA-Based Biomaterials Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Collagen and HA-Based Biomaterials Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Collagen and HA-Based Biomaterials Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Collagen and HA-Based Biomaterials Sales by Type (2015-2020) (K MT)
Table 69. Middle East and Africa Collagen and HA-Based Biomaterials Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Collagen and HA-Based Biomaterials Sales by Application (2015-2020) (K MT)
Table 71. Middle East and Africa Collagen and HA-Based Biomaterials Sales Market Share by Application (2015-2020)
Table 72. Johnson & Johnson Corporation Information
Table 73. Johnson & Johnson Description and Major Businesses
Table 74. Johnson & Johnson Collagen and HA-Based Biomaterials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 75. Johnson & Johnson Product
Table 76. Johnson & Johnson Recent Development
Table 77. Alcon Laboratories(US) Corporation Information
Table 78. Alcon Laboratories(US) Description and Major Businesses
Table 79. Alcon Laboratories(US) Collagen and HA-Based Biomaterials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Alcon Laboratories(US) Product
Table 81. Alcon Laboratories(US) Recent Development
Table 82. Allergan(US) Corporation Information
Table 83. Allergan(US) Description and Major Businesses
Table 84. Allergan(US) Collagen and HA-Based Biomaterials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Allergan(US) Product
Table 86. Allergan(US) Recent Development
Table 87. Anika Therapeutics(US) Corporation Information
Table 88. Anika Therapeutics(US) Description and Major Businesses
Table 89. Anika Therapeutics(US) Collagen and HA-Based Biomaterials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Anika Therapeutics(US) Product
Table 91. Anika Therapeutics(US) Recent Development
Table 92. Bausch & Lomb(US) Corporation Information
Table 93. Bausch & Lomb(US) Description and Major Businesses
Table 94. Bausch & Lomb(US) Collagen and HA-Based Biomaterials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Bausch & Lomb(US) Product
Table 96. Bausch & Lomb(US) Recent Development
Table 97. Collagen Solutions Plc. (UK) Corporation Information
Table 98. Collagen Solutions Plc. (UK) Description and Major Businesses
Table 99. Collagen Solutions Plc. (UK) Collagen and HA-Based Biomaterials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Collagen Solutions Plc. (UK) Product
Table 101. Collagen Solutions Plc. (UK) Recent Development
Table 102. Galderma (Switzerland) Corporation Information
Table 103. Galderma (Switzerland) Description and Major Businesses
Table 104. Galderma (Switzerland) Collagen and HA-Based Biomaterials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Galderma (Switzerland) Product
Table 106. Galderma (Switzerland) Recent Development
Table 107. Genzyme (US) Corporation Information
Table 108. Genzyme (US) Description and Major Businesses
Table 109. Genzyme (US) Collagen and HA-Based Biomaterials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Genzyme (US) Product
Table 111. Genzyme (US) Recent Development
Table 112. Lifecore Biomedical, LLC (US) Corporation Information
Table 113. Lifecore Biomedical, LLC (US) Description and Major Businesses
Table 114. Lifecore Biomedical, LLC (US) Collagen and HA-Based Biomaterials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Lifecore Biomedical, LLC (US) Product
Table 116. Lifecore Biomedical, LLC (US) Recent Development
Table 117. Seikagaku Corp. (Japan) Corporation Information
Table 118. Seikagaku Corp. (Japan) Description and Major Businesses
Table 119. Seikagaku Corp. (Japan) Collagen and HA-Based Biomaterials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Seikagaku Corp. (Japan) Product
Table 121. Seikagaku Corp. (Japan) Recent Development
Table 122. Teijin Pharma Limited (Japan) Corporation Information
Table 123. Teijin Pharma Limited (Japan) Description and Major Businesses
Table 124. Teijin Pharma Limited (Japan) Collagen and HA-Based Biomaterials Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. Teijin Pharma Limited (Japan) Product
Table 126. Teijin Pharma Limited (Japan) Recent Development
Table 127. Global Collagen and HA-Based Biomaterials Sales Forecast by Regions (2021-2026) (K MT)
Table 128. Global Collagen and HA-Based Biomaterials Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Collagen and HA-Based Biomaterials Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Collagen and HA-Based Biomaterials Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Collagen and HA-Based Biomaterials Sales Forecast by Country (2021-2026) (K MT)
Table 132. North America: Collagen and HA-Based Biomaterials Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Collagen and HA-Based Biomaterials Sales Forecast by Country (2021-2026) (K MT)
Table 134. Europe: Collagen and HA-Based Biomaterials Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Collagen and HA-Based Biomaterials Sales Forecast by Region (2021-2026) (K MT)
Table 136. Asia Pacific: Collagen and HA-Based Biomaterials Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Collagen and HA-Based Biomaterials Sales Forecast by Country (2021-2026) (K MT)
Table 138. Latin America: Collagen and HA-Based Biomaterials Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Collagen and HA-Based Biomaterials Sales Forecast by Country (2021-2026) (K MT)
Table 140. Middle East and Africa: Collagen and HA-Based Biomaterials Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Collagen and HA-Based Biomaterials Players
Table 145. Collagen and HA-Based Biomaterials Customers List
Table 146. Collagen and HA-Based Biomaterials Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Collagen and HA-Based Biomaterials Product Picture
Figure 2. Global Collagen and HA-Based Biomaterials Sales Market Share by Type in 2020 & 2026
Figure 3. Urinary Incontinence Product Picture
Figure 4. Corneal Shields Product Picture
Figure 5. Facial Aesthetic Dermal Fillers Product Picture
Figure 6. Wound Dressings Product Picture
Figure 7. Others Product Picture
Figure 8. Global Collagen and HA-Based Biomaterials Sales Market Share by Application in 2020 & 2026
Figure 9. Cosmetology
Figure 10. Wound Care
Figure 11. Others
Figure 12. Collagen and HA-Based Biomaterials Report Years Considered
Figure 13. Global Collagen and HA-Based Biomaterials Market Size 2015-2026 (US$ Million)
Figure 14. Global Collagen and HA-Based Biomaterials Sales 2015-2026 (K MT)
Figure 15. Global Collagen and HA-Based Biomaterials Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Collagen and HA-Based Biomaterials Sales Market Share by Region (2015-2020)
Figure 17. Global Collagen and HA-Based Biomaterials Sales Market Share by Region in 2019
Figure 18. Global Collagen and HA-Based Biomaterials Revenue Market Share by Region (2015-2020)
Figure 19. Global Collagen and HA-Based Biomaterials Revenue Market Share by Region in 2019
Figure 20. Global Collagen and HA-Based Biomaterials Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Collagen and HA-Based Biomaterials Revenue in 2019
Figure 22. Collagen and HA-Based Biomaterials Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Collagen and HA-Based Biomaterials Sales Market Share by Type (2015-2020)
Figure 24. Global Collagen and HA-Based Biomaterials Sales Market Share by Type in 2019
Figure 25. Global Collagen and HA-Based Biomaterials Revenue Market Share by Type (2015-2020)
Figure 26. Global Collagen and HA-Based Biomaterials Revenue Market Share by Type in 2019
Figure 27. Global Collagen and HA-Based Biomaterials Market Share by Price Range (2015-2020)
Figure 28. Global Collagen and HA-Based Biomaterials Sales Market Share by Application (2015-2020)
Figure 29. Global Collagen and HA-Based Biomaterials Sales Market Share by Application in 2019
Figure 30. Global Collagen and HA-Based Biomaterials Revenue Market Share by Application (2015-2020)
Figure 31. Global Collagen and HA-Based Biomaterials Revenue Market Share by Application in 2019
Figure 32. North America Collagen and HA-Based Biomaterials Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Collagen and HA-Based Biomaterials Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Collagen and HA-Based Biomaterials Sales Market Share by Country in 2019
Figure 35. North America Collagen and HA-Based Biomaterials Revenue Market Share by Country in 2019
Figure 36. U.S. Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Collagen and HA-Based Biomaterials Market Share by Type in 2019
Figure 41. North America Collagen and HA-Based Biomaterials Market Share by Application in 2019
Figure 42. Europe Collagen and HA-Based Biomaterials Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Collagen and HA-Based Biomaterials Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Collagen and HA-Based Biomaterials Sales Market Share by Country in 2019
Figure 45. Europe Collagen and HA-Based Biomaterials Revenue Market Share by Country in 2019
Figure 46. Germany Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Collagen and HA-Based Biomaterials Market Share by Type in 2019
Figure 57. Europe Collagen and HA-Based Biomaterials Market Share by Application in 2019
Figure 58. Asia Pacific Collagen and HA-Based Biomaterials Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Collagen and HA-Based Biomaterials Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Collagen and HA-Based Biomaterials Sales Market Share by Region in 2019
Figure 61. Asia Pacific Collagen and HA-Based Biomaterials Revenue Market Share by Region in 2019
Figure 62. China Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Collagen and HA-Based Biomaterials Market Share by Type in 2019
Figure 85. Asia Pacific Collagen and HA-Based Biomaterials Market Share by Application in 2019
Figure 86. Latin America Collagen and HA-Based Biomaterials Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Collagen and HA-Based Biomaterials Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Collagen and HA-Based Biomaterials Sales Market Share by Country in 2019
Figure 89. Latin America Collagen and HA-Based Biomaterials Revenue Market Share by Country in 2019
Figure 90. Mexico Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Collagen and HA-Based Biomaterials Market Share by Type in 2019
Figure 97. Latin America Collagen and HA-Based Biomaterials Market Share by Application in 2019
Figure 98. Middle East and Africa Collagen and HA-Based Biomaterials Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Collagen and HA-Based Biomaterials Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Collagen and HA-Based Biomaterials Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Collagen and HA-Based Biomaterials Revenue Market Share by Country in 2019
Figure 102. Turkey Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Collagen and HA-Based Biomaterials Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Collagen and HA-Based Biomaterials Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Collagen and HA-Based Biomaterials Market Share by Type in 2019
Figure 109. Middle East and Africa Collagen and HA-Based Biomaterials Market Share by Application in 2019
Figure 110. North America Collagen and HA-Based Biomaterials Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. North America Collagen and HA-Based Biomaterials Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Collagen and HA-Based Biomaterials Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Europe Collagen and HA-Based Biomaterials Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Collagen and HA-Based Biomaterials Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Asia Pacific Collagen and HA-Based Biomaterials Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Collagen and HA-Based Biomaterials Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Latin America Collagen and HA-Based Biomaterials Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Collagen and HA-Based Biomaterials Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Middle East and Africa Collagen and HA-Based Biomaterials Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed


【掲載企業】

Johnson & Johnson、Alcon Laboratories(US)、Allergan(US)、Anika Therapeutics(US)、Bausch & Lomb(US)、Collagen Solutions Plc. (UK)、Galderma (Switzerland)、Genzyme (US)、Lifecore Biomedical, LLC (US)、Seikagaku Corp. (Japan)、Teijin Pharma Limited (Japan)

★調査レポート[世界のコラーゲン・HAベース生体材料市場インサイト及び予測(~2026年)] (コード:QYR20NV00409)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のコラーゲン・HAベース生体材料市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆